CLINSQUARE: CLINICAL RESEARCH COURSES
Sunday, April 20, 2025
CLINSQUARE: Clinical Rsearch Courses by LIFEPRONOW
HomeLatest Pharma-News

Latest Pharma-News

Latest Pharma-News

TG Therapeutics Initiates Rolling Submission of NDA to U.S. FDA for Umbralisib as a Treatment for Patients with Previously Treated Marginal Zone Lymphoma or...

admin - 0
Latest Pharma-News

FDA Grants Fast Track Designation to Arena Pharmaceuticals’ APD418 for Development for the treatment Decompensated Heart Failure Patients

admin - 0
Latest Pharma-News

The U.S. FDA is alertes safety clinical trial shows possible increased risk of cancer with weight-loss medicine Belviq, Belviq XR (lorcaserin)

admin - 0
Latest Pharma-News

Bristol-Myers Squibb Company announced U.S. FDA accepted its supplemental Biologics License Application (sBLA) for Opdivo (nivolumab) plus Yervoy (ipilimumab) for first-line...

admin - 0
Latest Pharma-News

Imago Receives Fast Track Designation from U.S. FDA for Bomedemstat for the Treatment of Essential Thrombocythemia

admin - 0
Latest Pharma-News

MorphoSys and Incyte Sign Global Collaboration and License Agreement for Tafasitamab development for the treatment of the B cell malignancies

admin - 0
Latest Pharma-News

CytoDyn Files for Breakthrough Therapy Designation with the FDA for the Use of Leronlimab as an adjuvant therapy for the Treatment of Metastatic Triple-Negative...

admin - 0
Latest Pharma-News

Ultragenyx and Kyowa Kirin Announce Submission of Supplemental Biologics License Application to U.S. FDA for Crysvita® (burosumab) for the treatment of Tumor-Induced Osteomalacia (TIO)

admin - 0
Latest Pharma-News

BioCryst to Provide Berotralstat and BCX9930 Program Updates at 38th Annual J.P. Morgan Healthcare Conference

admin - 0
Latest Pharma-News

FDA grants breakthrough device designation to Reflow Medical’s temporary spur stent system for the treatment of below-the-knee (BTK) peripheral artery disease

admin - 0
Latest Pharma-News

Novartis ligelizumab (QGE031) more effective than Xolair®(omalizumab) at inhibiting immunoglobulin E pathway responsible for chronic spontaneous urticaria

admin - 0
Latest Pharma-News

Bayer and Evotec form a new strategic alliance focusing on the treatment of polycystic ovary syndrome

admin - 0
1...133134135...145Page 134 of 145
- Advertisment -

Most Read

EDITOR PICKS

POPULAR POSTS

POPULAR CATEGORY

ABOUT US

LifeProNow provides guidance and high quality contents to help job seekers to get their dream Job. All the contents are written by experienced folks and peer reviewed by experts.

Contact us: [email protected]

FOLLOW US

© LifeProNow | All Rights Reserved